Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
51,368,292
-
Total 13F shares
-
21,481,792
-
Share change
-
+42,308
-
Total reported value
-
$371,408,185
-
Price per share
-
$17.29
-
Number of holders
-
65
-
Value change
-
+$679,329
-
Number of buys
-
31
-
Number of sells
-
25
Institutional Holders of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) as of Q2 2021
As of 30 Jun 2021,
Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,481,792 shares.
The largest 10 holders included
NEA Management Company, LLC, FRAZIER MANAGEMENT LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Novo Holdings A/S, Rock Springs Capital Management LP, VANGUARD GROUP INC, AXA S.A., BAKER BROS. ADVISORS LP, BlackRock Inc., and Sio Capital Management, LLC.
This page lists
65
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.